Cargando…

Pulmonary Arterial Hypertension: Pathophysiology and Treatment

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a chronic and progressive disorder characterised by angioproliferative vasculopathy in the pulmonary arterioles, leading to endothelial and smooth muscle proliferation and dysfunction, inflammation and thrombosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Norris S. H., Massam, Benjamin D., Kulkarni, Sandeep S., Lang, Chim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023499/ https://www.ncbi.nlm.nih.gov/pubmed/29772649 http://dx.doi.org/10.3390/diseases6020038

Ejemplares similares

Pulmonary arterial hypertension: Advances in pathophysiology and management
por: Chopra, Sandeep, et al.
Publicado: (2012)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension
por: Otani, Naoyuki, et al.
Publicado: (2023)

Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

The pathophysiology of chronic thromboembolic pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2017)

Pathophysiology and new advances in pulmonary hypertension
por: Bousseau, Simon, et al.
Publicado: (2023)

Palliative care in pulmonary arterial hypertension: an underutilised treatment
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
por: Baroutidou, Amalia, et al.
Publicado: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009)

Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
por: Sánchez-Gloria, José L., et al.
Publicado: (2020)

Hypertension in pregnancy: Pathophysiology and treatment
por: Braunthal, Stephanie, et al.
Publicado: (2019)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
por: Friedman, Scott E., et al.
Publicado: (2012)

Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension
por: Barbeau, Solène, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
por: Wells, J Michael, et al.
Publicado: (2013)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
por: Stącel, Tomasz, et al.
Publicado: (2021)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
por: Otani, Naoyuki, et al.
Publicado: (2022)

Renovascular Hypertension: Pathophysiology, Diagnosis, and Treatment
por: Black, Henry R., et al.
Publicado: (1978)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
por: Lang, Irene M., et al.
Publicado: (2015)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Novel Treatment Pathways in Pulmonary Arterial Hypertension
por: Qaiser, Kanza N., et al.
Publicado: (2021)

Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes
por: Elshaboury, Soha M, et al.
Publicado: (2013)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

Pulmonary arterial hypertension: the case for a bioelectronic treatment
por: Ntiloudi, Despοina, et al.
Publicado: (2019)

Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
por: Zolty, Ronald
Publicado: (2021)

New progress in diagnosis and treatment of pulmonary arterial hypertension
por: Zhang, Zai-qiang, et al.
Publicado: (2022)

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Hyponatremia in patients with arterial hypertension: pathophysiology and management
por: Adamczak, Marcin, et al.
Publicado: (2023)

Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management
por: Ltaief, Zied, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m01i826cfro95oagk0r1803l86